IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
Go back to IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation| (NASDAQ: IMDX) | Delayed: 4.27 +0.14 (3.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $ | |||
| Open | $4.13 | 52 Week Low | $ | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $ | |||
| Volume | 212,818 | |||||

